Abstract
BackgroundPopulation-level knowledge on individuals at high risk of severe and fatal coronavirus disease 2019 (COVID-19) is urgently needed to inform targeted protection strategies in the general population.MethodsWe examined characteristics and predictors of hospitalization and death in a nationwide cohort of all Danish individuals tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from 27 February 2020 until 19 May 2020.ResultsWe identified 11 122 SARS-CoV-2 polymerase chain reaction-positive cases of whom 80% were community-managed and 20% were hospitalized. Thirty-day all-cause mortality was 5.2%. Age was strongly associated with fatal disease {odds ratio [OR] 15 [95% confidence interval (CI): 9–26] for 70–79 years, increasing to OR 90 (95% CI: 50–162) for ≥90 years, when compared with cases aged 50–59 years and adjusted for sex and number of co-morbidities}. Similarly, the number of co-morbidities was associated with fatal disease [OR 5.2 (95% CI: 3.4–8.0), for cases with at least four co-morbidities vs no co-morbidities] and 79% of fatal cases had at least two co-morbidities. Most major chronic diseases were associated with hospitalization, with ORs ranging from 1.3–1.4 (e.g. stroke, ischaemic heart disease) to 2.6–3.4 (e.g. heart failure, hospital-diagnosed kidney disease, organ transplantation) and with mortality with ORs ranging from 1.1–1.3 (e.g. ischaemic heart disease, hypertension) to 2.5–3.2 (e.g. major psychiatric disorder, organ transplantation). In the absence of co-morbidities, mortality was <5% in persons aged ≤80 years.ConclusionsIn this nationwide population-based COVID-19 study, increasing age and multimorbidity were strongly associated with hospitalization and death. In the absence of co-morbidities, the mortality was, however, <5% until the age of 80 years.
Highlights
Despite worldwide efforts to prevent the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the derived coronavirus disease 2019 (COVID-19) has become a global pandemic
We describe clinical characteristics and predictors of hospitalization and death for all SARS-CoV-2 polymerase chain reaction (PCR)-positive cases in Denmark, where early lockdown and surplus healthcare capacity during the epidemic may have influenced the risk of critical disease
In this population-based study of a Danish COVID-19 cohort capturing all individuals with a positive PCR test for SARS-CoV-2 in Denmark, we provide nationwide data on clinical characteristics and predictors of hospitalization and death for all SARS-CoV-2 PCR-positive cases identified from 27 February 2020 to 19 May 2020
Summary
Despite worldwide efforts to prevent the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the derived coronavirus disease 2019 (COVID-19) has become a global pandemic. Hospital-based case series from the early stages of the pandemic have suggested that patients with severe and fatal COVID-19 are likely to be older men with a high burden of co-morbid diseases.[3,4,5,6,7] Most previous studies were, restricted to hospitals and selected populations in areas where the healthcare systems were overwhelmed by the epidemic. We describe clinical characteristics and predictors of hospitalization and death for all SARS-CoV-2 polymerase chain reaction (PCR)-positive cases in Denmark, where early lockdown and surplus healthcare capacity during the epidemic may have influenced the risk of critical disease. Methods: We examined characteristics and predictors of hospitalization and death in a nationwide cohort of all Danish individuals tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from 27 February 2020 until 19 May 2020.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.